Dr. Harry W. Matelski, MD

  • New Bedford, MA
  • Hematologist and oncologist
NPI1699737874PAC ID1759337876
Medicare services, 2024
568
Medicare patients, 2024
236
Part D claims, 2024
262
Hospital affiliations
1
Industry payments
$140
Practice address
101 Page St, New Bedford, MA 02740
Practice phone
Call (508) 997-1515
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

St Lukes Hospital

New Bedford, Massachusetts

See all 10 affiliations

Find Dr. Matelski's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Harry W. Matelski is a hematologist and oncologist in New Bedford, Massachusetts

Dr. Matelski practices at St Lukes Hospital in New Bedford, Massachusetts.

Dr. Matelski's NPI, 1699737874, was assigned on April 4, 2006. Dr. Matelski graduated from Hahnemann University College of Medicine in 1977. Dr. Matelski holds Massachusetts license 47369.

NPI and contact details
Medicare PAC ID
1759337876
NPI enumeration date
April 4, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(508) 997-1515
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
75
Medical school graduation
1977

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Harry W. Matelski practices at St Lukes Hospital in New Bedford, Massachusetts

Dr. Matelski's primary practice is St Lukes Hospital, at 101 Page St, New Bedford, MA 02740 in Bristol County. The practice phone is (508) 997-1515.

  • St Lukes Hospital
    101 Page St, New Bedford, MA 02740 · Bristol CountyPhone(508) 997-1515

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Harry W. Matelski is affiliated with 6 sites of care and 4 medical groups

Dr. Matelski's primary practice is St Lukes Hospital in New Bedford, Massachusetts. Dr. Matelski is also affiliated with Charlton Memorial Hospital. The medical group on file is Southcoast Health. Dmand AI also links Dr. Matelski to 4 more group practices and clinics and 3 medical groups, each named with a free account.

See all 10 affiliations for Dr. Matelski

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Harry W. Matelski's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Matelski practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
St Lukes HospitalAvailable with a free account
+5 more sites and 3 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Matelski practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Harry W. Matelski is one of 429 hematologists and oncologists in Massachusetts

Hematology and oncology is Dr. Matelski's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Matelski is licensed in Massachusetts.

Specialties and state licenses

  • Hematology and oncology, MassachusettsPrimaryLicense 47369 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Matelski

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

429hematologists and oncologists in Massachusetts
3hematologists and oncologists in New Bedford

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Harry W. Matelski billed Medicare for 568 services in 2024

CMS data shows 568 Medicare services from Dr. Matelski across 4 procedure codes in 2024, all of them office visits, for 236 Medicare patients. Medicare paid $41,987 for them. Every service was in an office.

Medicare services, 2024568
Medicare patients236
Paid by Medicare$41,987
Procedure codes4

Dr. Matelski's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 6292024: 56810%

Dr. Matelski compared with the Massachusetts median for hematologists and oncologists, 2024

  • Dr. Matelski
  • Massachusetts median
Medicare services
568vs 49515% above
Medicare patients
236vs 20018% above
Part D claims
136vs 15110% below

Medians across 415 hematologists and oncologists in Massachusetts with Dmand AI profiles that report each measure.

Dr. Matelski's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Matelski

Need commercial claims for Dr. Matelski?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Matelski and other hematologists and oncologists in Massachusetts.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Harry W. Matelski treated 236 Medicare patients in 2024, average age 74

CMS counts 236 Medicare patients who saw Dr. Matelski in 2024. The largest group is 65 to 74, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Matelski's median patient age at 72, with 58% women.

Medicare patients, 2024236
Average age74
Average risk score1.94
Also on Medicaid32%

Dr. Matelski's Medicare patients by age, 2024

Dr. Matelski's Medicare patients by sex, 2024

  • Women13658%
  • Men10042%

Chronic conditions among Dr. Matelski's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis58%
  4. Ischemic heart disease40%
  5. Anxiety39%
  6. Cancer38%
  7. Diabetes33%
  8. Chronic kidney disease31%

Share of Medicare patients with each condition. A patient can have several.

Dr. Matelski's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women58%
  • Men41%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Harry W. Matelski wrote 262 Medicare Part D claims in 2024

In 2024, Dr. Matelski wrote 262 Medicare Part D claims for 74 patients. 76% of them were for generic drugs. CMS names the drug for 136 of them, across 6 drugs with 11 or more claims each, at $24,033 in total drug cost. In 2023, CMS named 395 claims across 16 drugs.

Part D claims, 2024262
Drugs named by CMS6
Total drug cost$24,033
Part D patients74

Dr. Matelski's Part D claims by kind of drug, 2024

  • Generic200 claims76%
  • Brand-name62 claims24%

Dr. Matelski's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Matelski's Part D claims, 2024

  • Opioids6%15 of 262 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3952024: 13666%

Drugs named by CMS: 6 in 2024, 16 in 2023.

See all prescribing by Dr. Matelski

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Harry W. Matelski offers telehealth to Medicare patients

Dr. Matelski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Matelski as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Matelski by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Harry W. Matelski received $140 in industry payments from 2018 to 2024

CMS Open Payments shows 6 general payments to Dr. Matelski from 5 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 65% of the total. AstraZeneca Pharmaceuticals LP paid the most, $57.

General payments to Dr. Matelski by program year, 2018 to 2024

General payments to Dr. Matelski by kind, 2018 to 2024

$140in total
  • Food and beverage$9065%
  • Education$5035%

Companies that paid Dr. Matelski the most, 2018 to 2024

Share is of all general payments to this clinician.

See all payments to Dr. Matelski

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Harry W. Matelski graduated from Hahnemann University College of Medicine

Dr. Matelski graduated from Hahnemann University College of Medicine in 1977.

  1. Medical schoolHahnemann University College of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Harry W. Matelski's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Harry W. Matelski

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Harry W. Matelski's NPI number?

Dr. Harry W. Matelski's NPI number is 1699737874. It was assigned on April 4, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Harry W. Matelski?

Dr. Harry W. Matelski is a hematologist and oncologist in New Bedford, Massachusetts. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Harry W. Matelski practice?

Dr. Matelski practices at 101 Page St, New Bedford, MA 02740. Dr. Matelski's primary practice is St Lukes Hospital in New Bedford, Massachusetts. Dmand AI also links Dr. Matelski to 4 group practices and clinics and 3 medical groups.

What is Dr. Harry W. Matelski's office phone number?

The practice phone on file for Dr. Matelski is (508) 997-1515.

What is Dr. Harry W. Matelski's medical license number?

Dr. Matelski holds Massachusetts license 47369.

Which hospitals is Dr. Harry W. Matelski affiliated with?

Dr. Matelski is affiliated with Charlton Memorial Hospital.

What medical group is Dr. Harry W. Matelski part of?

Dr. Matelski is linked to Southcoast Health. Dmand AI links Dr. Matelski to 3 more medical groups.

Does Dr. Harry W. Matelski accept Medicare?

Yes. CMS data shows Dr. Matelski billed Medicare for 568 services in 2024, and Dr. Matelski accepts Medicare assignment.

Does Dr. Harry W. Matelski offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Matelski as offering telehealth services.

How many Medicare patients does Dr. Harry W. Matelski see?

CMS counts 236 Medicare patients who saw Dr. Matelski in 2024, with an average age of 74.

Show 5 more questionsShow fewer questions

What services does Dr. Harry W. Matelski bill to Medicare?

In 2024, Dr. Matelski's most billed Medicare services were office visit, established patient (99213), office visit, established patient (99214) and office visit, new patient (99203).

Where did Dr. Harry W. Matelski go to medical school?

Dr. Matelski graduated from Hahnemann University College of Medicine in 1977.

What drugs does Dr. Harry W. Matelski prescribe most?

In 2024 Medicare Part D data, Dr. Matelski's most prescribed drugs by claims were Warfarin Sodium, Anastrozole and Enoxaparin Sodium.

Has Dr. Harry W. Matelski received payments from drug or device companies?

CMS Open Payments shows $140 in general payments to Dr. Matelski from 5 companies from 2018 to 2024. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Harry W. Matelski been practicing?

Dr. Matelski graduated from medical school in 1977, 49 years ago.

Selling to hematology and oncology practices?

See hematologists and oncologists in Massachusetts by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)